Molar Incisor Hypomineralization and Hypomineralized Second Primary Molars
Prevalence and Clinical Characteristics of Molar Incisor Hypomineralization (MIH) and Hypomineralized Second Primary Molars (HSPM) Among Italian, Spanish and Turkish Children: a Multicenter Epidemiological Study
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Milena Cadenaro, MD
- Phone Number: +390403785
- Email: milena.cadenaro@burlo.trieste.it
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age: 6-16 years;
- Signature of the informed consent to the study by patients' parents or by their legal guardians
Exclusion Criteria:
- Fluorosis, white spots, amelogenesis imperfecta, hypoplasia or other dental enamel defects in differential diagnosis with MIH and HSPM;
- Patients not sufficiently cooperative;
- Children with orthodontic devices hiding the teeth to consider
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MIH prevalence rate
Time Frame: At baseline (day one)
|
Prevalence of the condition in the populations studied
|
At baseline (day one)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Description of MIH clinical characteristics
Time Frame: At baseline (day one)
|
Description of the clinical characteristics of MIH, evaluated by questionnaire
|
At baseline (day one)
|
|
Frequency of the most frequently affected teeth
Time Frame: At baseline (day one)
|
Evaluated by questionnaire
|
At baseline (day one)
|
|
Association between HSPM and MIH development
Time Frame: At baseline (day one)
|
Evaluated by questionnaire
|
At baseline (day one)
|
|
Association between MIH/HSPM and presence of caries
Time Frame: At baseline (day one)
|
Evaluated by questionnaire
|
At baseline (day one)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Milena Cadenaro, MD, IRCCS materno infantile Burlo Garofolo
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RC 11/21
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.